Navigation Links
Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/12/2009

324,875 Convertible preferred stock: $0.001 par value; 7,593,091 shares authorized; 0 shares issued and outstanding at September 30, 2009; Series A - 60,212, Series B - 1,126,020, Series C - 2,838,091 and Series D - 3,325,647 shares issued and outstanding at December 31, 2008 - 71,036,951 Stockholders' equity (net capital deficiency): Common stock, $0.001 par value; 100,000,000 shares authorized; 13,336,431 and 454,676 shares issued and outstanding at September 30, 2009 and December 31, 2008, respectively 13,336 455 Additional paid-in capital 157,516,702 1,503,841 Accumulated deficit (84,567,159) (65,111,433) Accumulated other comprehensive income 64,758 25,825 ------ ------ Total stockholders' equity (net capital deficiency) 73,027,637 (63,581,312) ---------- ----------- Total liabilities, convertible preferred stock and stockholders' equity (net capital deficiency) $100,016,740 $13,780,514 ============ ===========
    Contact:

    Transcept Pharmaceuticals, Inc.
    Greg Mann
    Director, Corporate Communications
    (510) 215-3567
    gmann@transcept.com

SOURCE Transcept Pharmaceuticals, Inc.


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
4. Transcept Pharmaceuticals to Report First Quarter 2009 Results
5. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
6. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
8. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
9. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
10. Endo Pharmaceuticals and LecTec Settle Patent Dispute
11. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... with buyers to divest in the United ... assets, Biomet Discovery® Elbow System assets and Cobalt™ bone ... Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... constructively with the Bureau of Competition Staff of the ...
(Date:5/28/2015)... 28, 2015 Henry Schein , ... of health care products and services to office-based ... its customers that the Henry Schein Disaster Relief ... who experience operational, logistical or financial issues as ... South Central region of the U.S. The toll-free ...
(Date:5/28/2015)... 28, 2015 Research and ... of the "United States Medical Adhesives Market ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the United States is projected ... Medical device manufacturers across the US are ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3
... Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical ... that treat women,s reproductive system disorders, today announced ... (USPTO) has issued a notice of allowance of ... an Aromatase Inhibitor, a Progestin, and an Oestrogen ...
... DIEGO, Sept. 8 ResMed Inc. (NYSE: RMD ... company,s outstanding shares of common stock, payable in the form ... 2010. The new total shares outstanding doubled to 151,388,240 shares, ... the company,s common stock on the New York Stock Exchange ...
Cached Medicine Technology:Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis 2Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis 3
(Date:5/28/2015)... Calgary, AB (PRWEB) May 28, 2015 ... the world and all over the United States. There ... of heart disease, who can experience symptoms of angina ... cardiac medications, heart stents and/or bypass surgery. , “No ... angina due to coronary artery disease that is considered ...
(Date:5/28/2015)... 2015 AMVETS National Executive Director Stewart ... on Care established by Congress to examine how to ... Appointed to the commission by Mitch McConnell, majority leader ... of only 15 voting members on the panel, which ... Act of 2014. The goal of the commission is ...
(Date:5/28/2015)... Park Cities Pet Sitter is offering a 5-week “Training ... Saturday, June 6th at 10:30am. The classes will be ... Dallas, with a maximum of six dogs allowed in the ... no class being held over the 4th of July weekend. ... Intermediate-to-Advanced level class, dogs will solidify their practical behavior skills, ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 New ... Rafizadeh, specializes in delivering world-class results. With over ... Surgery and a background in art, Dr. Rafizadeh knows ... His unique approach to Plastic Surgery involves the principles ... practice delivers a superior level of comfort and personalized ...
(Date:5/28/2015)... As the summer approaches, many people will ... important to make safety a top priority, however, and that’s ... , According to the Centers for Disease Control, 10 people ... including boating incidents. Additionally, the National Safety Council says drowning ... to 4. , Amica is sharing the following tips ...
Breaking Medicine News(10 mins):Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:Splash! Amica Shares 6 Swimming Safety Tips 2
... ... a dental tourism facilitator specializing only in dentistry that is dedicated to helping patients ... ... After years of expensive visits to the dentist, Jeff Apton emerged from retirement to ...
... , Jan. 19 , Disaster Statistics ... over 100,000 3 million people displaced or otherwise impacted by earthquake ... million) , Conditions in Port-au-Prince ... scattered across 243 different locations in Port-au-Prince . In addition, ...
... linked to an increase in the likelihood of developing lung ... journal BMC Public Health describe how the link ... victims of childhood trauma, but note that other factors may ... from the Centers for Disease Control and Prevention, Atlanta, USA, ...
... suggest that expenses for systemic psoriasis therapy appear to ... newer biologically derived treatments are more expensive than traditional ... issue of Archives of Dermatology , one of ... disease that affects an estimated 4.5 million to 7.5 ...
... Increases outpace consumer products as well as other meds, ... The cost of treating psoriasis is rising faster than ... newer, biologically-derived treatments cost more than traditional systemic therapies. ... the total cost of systemic therapy for psoriasis, a ...
... , CARY, N.C. , Jan. 18 ... Tobacco Road Marathon to be conducted in Cary, North Carolina ... announced today. The event is now officially named the "Duke Medicine Tobacco ... join us in making Cary,s first marathon a reality," ...
Cached Medicine News:Health News:Snatched from the Jaws of Retirement: Spiraling Treatment Costs Push Senior To Start Pan American Dental Tours 2Health News:Snatched from the Jaws of Retirement: Spiraling Treatment Costs Push Senior To Start Pan American Dental Tours 3Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 2Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 3Health News:Childhood harms can lead to lung cancer 2Health News:Costs of psoriasis treatments outpace inflation 2Health News:Cost of Psoriasis Drugs Rising Faster Than Others 2Health News:Duke Medicine Becomes Tobacco Road Marathon Title Sponsor 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: